# FAPI PET Imaging - An Exploratory Study

> **NCT07705074** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Martin Huellner** · enrollment: 770 (estimated)

## Conditions studied

- Thyroid Pathology
- Head and Neck Cancer (H&N)
- Sinonasal Tract Tumor
- Sarcoidosis
- Thyroid Cancer
- Breast Cancer
- Hepatocellular Carcinoma (HCC)
- Gastric Cancer (GC)
- Pancreatic Cancer, Adult
- Urothelial Carcinoma (UC)
- Multiple Myeloma or Plasmacytoma
- Mesothelioma
- Hepatic Fibrosis
- Endometriosis (Diagnosis)
- Lung Fibrosis
- Neck Node Metastasis
- Prostate Cancer (CRPC)

## Interventions

- **DRUG:** [18F]FAPI-74 PET/CT

## Key facts

- **NCT ID:** NCT07705074
- **Lead sponsor:** Martin Huellner
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2029-09
- **Final completion:** 2029-09
- **Target enrollment:** 770 (ESTIMATED)
- **Last updated:** 2026-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07705074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07705074, "FAPI PET Imaging - An Exploratory Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07705074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*